Embecta (EMBC) Change in Receivables (2020 - 2026)
Embecta (EMBC) posted Change in Receivables of -$11.3 million for Q1 2026, down 194.17% sequentially from $12.0 million in Q4 2025, and down 638.1% YoY from $2.1 million in Q1 2025.
Embecta (EMBC) Change in Receivables (2020 - 2026) Analysis & Trends
Embecta has reported Change in Receivables for 7 years, with the latest figure at -$11.3 million in Q1 2026.
- Quarterly Change in Receivables fell 638.1% year-over-year to -$11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39.8 million (down 161.9% YoY) and the FY2025 annual result came in at -$44.2 million, down 125.3% from the prior year.
- Change in Receivables eased to -$11.3 million in Q1 2026 per EMBC's latest filing, from $12.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $78.6 million in Q4 2023 and troughed at -$102.6 million in Q1 2022.
- A 5-year average of $1.9 million and a median of $900000.0 in 2022 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables slumped 4004.0% in 2022, then surged 4025.0% in 2024.
- Over 5 years, Change in Receivables stood at -$3.0 million in 2022, then soared by 2720.0% to $78.6 million in 2023, then sank by 107.38% to -$5.8 million in 2024, then soared by 306.9% to $12.0 million in 2025, then tumbled by 194.17% to -$11.3 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$11.3 million, $12.0 million, and -$32.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.20 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.62 Bn | 51.76 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.73 Bn | 34.37 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.68 Bn | 32.21 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.26 Bn | 26.59 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.42 Bn | 15.02 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.52 Bn | 11.37 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Embecta | 305.55 Mn | 87.35 Mn | 153.30 Mn | 20.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.10 Mn |
| Jun 30, 2026 | 20.10 Mn |
| Mar 31, 2026 | -11.30 Mn |
| Mar 31, 2026 | -11.30 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Sep 30, 2025 | -32.50 Mn |
| Sep 30, 2025 | -32.50 Mn |
| Jun 30, 2025 | -8.00 Mn |
| Jun 30, 2025 | -8.00 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -5.80 Mn |
| Dec 31, 2024 | -5.80 Mn |
| Sep 30, 2024 | 18.50 Mn |
| Sep 30, 2024 | 18.50 Mn |
| Jun 30, 2024 | 49.50 Mn |
| Jun 30, 2024 | 49.50 Mn |
| Mar 31, 2024 | 28.10 Mn |
| Mar 31, 2024 | 28.10 Mn |